Skip To Main Content
Ma Lingying on Muck Rack

Ma Lingying

As seen in: Arthritis Research & Therapy, Medscape
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ma

Contact Ma, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

High level of serum complement 3 is a risk factor for vascular stenosis progression in TA patients receiving tocilizumab: a prospective observational study | Arthritis Research & Therapy | Full Text

|
By Chen Rongyi, Ma Lingying, Ma Lili, Sun Ying, Dai Xiaojuan, Wang Jinghua, Dai Xiaomin, Chen Huiyong, Jiang Lindi
| Arthritis Research & Therapy Verified
This prospective observational study focuses on VSP in TA patients treated with tocilizumab. Although tocilizumab was effective in alleviating inflammation and disease activity, approximately 47.3% of TA patients receiving tocilizumab showed VSP during the follow-up period. This finding was consistent with those of previous reports, which did not attract enough attention (Summarized in Supplementary Table S5). Furthermore, C3 was a predictive factor for VSP, with an AUC of 0.825 in 1 year.
Open in Who Shared Issue with article?

Predictors of Relapse in IgG4-Related Disease

|
By Ji Zongfei, Sun Ying, Chen Lingli, Ma Lingying
| Medscape Verified
Abstract and Introduction Abstract Objectives: In IgG4-related disease, the relationship between pathological findings and relapse has not been well established. This study aimed to identify the clinical and pathological predictors of disease relapse in IgG4-RD. Methods: Patients with newly diagnosed IgG4-RD (n = 71) were enrolled between January 2011 and April 2020; all cases were pathologically confirmed.
Open in Who Shared Issue with article?
See all 2 articles